EcoDrugPlus

Expressed Sequence Ai182371

Ensembl ID : ENSMSIG00000015637
Gene Symbol: AI182371
1 Cross references
207 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSMSIG00000029987
Gene Symbol: FNTA
1 Cross references
236 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSMSIG00000011223
Gene Symbol: FNTB
1 Cross references
224 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSMSIG00000015049
Gene Symbol: FAAH
1 Cross references
146 Possible Orthologues:

Fibroblast Activation Protein

Ensembl ID : ENSMSIG00000014217
Gene Symbol: FAP
1 Cross references
142 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSMSIG00000011514
Gene Symbol: FGF2
1 Cross references
132 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSMSIG00000020120
Gene Symbol: FGFR1
1 Cross references
304 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSMSIG00000007996
Gene Symbol: FGFR2
1 Cross references
232 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSMSIG00000020478
Gene Symbol: FGFR3
1 Cross references
211 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSMSIG00000017458
Gene Symbol: FGFR4
1 Cross references
138 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSMSIG00000001146
Gene Symbol: FOLH1
1 Cross references
225 Possible Orthologues:

Folate Receptor 1 (Adult)

Ensembl ID : ENSMSIG00000028445
Gene Symbol: FOLR1
1 Cross references
232 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).